Integrated Oncology Network and St. Joseph Medical Center Announce Affiliation in Houston, Texas
Houston (November 5, 2015) – Integrated Oncology Network, LLC and its subsidiary Sightline Health, LLC (“ION”) and St. Joseph’s Medical Center (“St. Joseph’s”), jointly announced today that ION’s Houston subsidiary, which operates two radiation centers in Houston, Texas (“Sightline Houston”) has formed an affiliation with St. Joseph’s, a leading hospital provider in Houston Texas. Sightline Houston will become an additional point of service for St. Joseph’s oncology network. St. Joseph Medical Center (SJMC) has been rebranded as St. Joseph Cancer Center.
“This acquisition is part of our strategic plan to extend St. Joseph’s reach beyond downtown and to deliver high quality healthcare services to more Houstonians,” said Mark Bernard, CEO of SJMC. “The November 2012 opening of St. Joseph Medical Center in the Heights began this initiative and it continues today as the cancer centers offer advanced treatments delivered by dedicated teams of nurses and staff who have all transitioned to be part of St. Joseph.”
“ION has been focused on expanding our networks across the United States of more than 250 multispecialty oncology-focused physicians to affiliate with larger providers and healthcare systems in their market to provide quality and cost efficient patient care. ION is honored to broaden our network with St. Joseph’s,” stated Jeffery Goffman, ION’s CEO and Co-Founder. “The St. Joseph’s relationship demonstrates our focus to affiliate and partner with leading hospitals, while maintaining our comprehensive physician network. We will continue to seek such prestigious hospital relationships in all of our markets.”
“We are excited to be working side-by-side with IASIS Healthcare and St. Joseph Medical Center to provide the latest in cancer care treatments to patients in the Houston and West Houston communities,” said Chris Bright, Chief Operating Officer of ION. “We are pleased to have found a partner in IASIS who shares our commitment to providing high-quality care to the communities we serve.”
Sightline Houston offers breakthrough technologies, including Intensity-Modulated Radiation Therapy (IMRT) and Image-Guided Radiation Therapy (IGRT), that offer new hope to individuals who are battling cancer. IMRT is the most technologically advanced and most precise method of external beam radiation therapy available. IGRT takes this technology one step further by delivering high doses of radiation directly to the treatment area while sparing surrounding tissue. Both therapies provide cancer treatment more precisely and with less risk, and both are beneficial for many different types of cancer.
About St. Joseph’s
St. Joseph Medical Center (SJMC), part of IASIS Healthcare, is a full service, general acute care hospital with two locations in downtown Houston and in the Heights. Celebrated as Houston’s first and only downtown hospital, the SJMC main campus has been providing a wide range of services to Greater Houston area residents for over 125 years. Services include a 24-hour Level III Emergency Center, behavioral medicine, cardiovascular surgery, cancer care, rehab and sports medicine, women’s services and more. For information about SJMC’s programs and services, visit www.sjmctx.com or call 713.757.1000.
Integrated Oncology Network, LLC and its subsidiaries (“ION” or the “Company”) is a radiation oncology management and cancer center development company that provides oncology solutions for physician practices and hospitals that seek strategic, financial, and management expertise. ION provides compliant solutions for joint ventures, development for cancer centers, financing, and management services with expertise in radiation oncology operations ION currently has investments in 21 radiation cancer centers in partnership with approximately 250 physicians, and 5 hospital systems. ION is a privately held company whose shareholders include a group of strategic investors, including Capricorn Investment Group and Comvest Group. For more information on ION, please visit our web site at www.ion-llc.com.
Statements in this Press Release that are not historical facts constitute “forward-looking statements.” Any statements contained herein which are not historical facts or which contain the words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “should,” and similar expressions are intended to identify forward-looking statements. Such statements reflect the current view of ION with respect to future events and are subject to certain risks, uncertainties and assumptions, including, but not limited to, the risk that ION may not be able to implement its growth strategy in the intended manner, including the ability to identify, finance, complete joint venture opportunities, risks regarding currently unforeseen competitive pressures and risks affecting ION’s industry, such as increased regulatory compliance and changes in regulatory requirements, changes in payor reimbursement levels. Should one or more of those risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein.